Trial intelligence / Profile preview

Propranolol eye drops in newborns with ROP

NCT02014454Phase 2Completed

Sponsor
Meyer Children's Hospital IRCCS
Start
Nov 2013
Primary completion
Aug 2014
Countries
1
01

Overview

A Phase 2 trial of propranolol in retinopathy of prematurity (ROP), sponsored by Meyer Children's Hospital IRCCS. Started Nov 2013; status: completed.

02

Drugs

propranolol
03

Conditions

retinopathy of prematurity (ROP)

Beyond the preview

Go deeper on NCT02014454.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02014454.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call